BEONE MEDICINES AG
[WKN: A41ANK | ISIN: CH1391448177]
Aktienkurse
20,300€ 2,57%
Echtzeit-Aktienkurs BEONE MEDICINES AG
Bid: Ask:

Echtzeit-Chart der BEONE MEDICINES AG Aktie

BEONE MEDICINES AG Chart

Charttool öffnen

Profil der BEONE MEDICINES AG Aktie

BeiGene Ltd. Is a global oncology company, which engages in providing pharmaceutical products. Its medicines include BRUKINSA, TEVIMBRA, and PARTRUVIX. The company was founded by Xiao Dong Wang and John V. Oyler on October 28, 2010 and is headquartered in George Town, KY.